tailieunhanh - Báo cáo hóa học: " Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành hóa học dành cho các bạn yêu hóa học tham khảo đề tài: Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses | Virology Journal BioMed Central Open Access Short report Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses Judit Szécsi1 2 3 Bertrand Boson1 2 3 Per Johnsson1 2 3 Pia Dupeyrot-Lacas1 2 3 4 Mikhail Matrosovich5 Hans-Dieter Klenk5 David Klatzmann6 Viktor Volchkov1 2 3 and Franẹois-Loĩc Cosset 1 2 3 Address 1INSERM U758 F-69007 Lyon France 2Ecole Normale Supérieure de Lyon F-69007 Lyon France 3IFR128 BioSciences Lyon-Gerland F-69007 Lyon France 4Epixis SA Lyon F-69007 Lyon France 5Institut fur Virologie Universitatsklinikum Giessen und Marburg D-35033 Marburg Germany and 6Laboratoire de Biologie et Thérapeutique des Pathologies Immunitaires CNRS-UMR7087 Université Pierre et Marie Curie Hôpital Pitié-Salpêtrière 83 Bd de l Hopital 75013 Paris France Email Judit Szécsi - Bertrand Boson - bboson@ Per Johnsson - Pia Dupeyrot-Lacas - Mikhail Matrosovich - Hans- Dieter Klenk - Klenk@ David Klatzmann - Viktor Volchkov - volchkov@ Franẹois-Loĩc Cosset - flcosset@ Corresponding author Published 03 September 2006 Received 16 August 2006 Accepted 03 September 2006 Virology journal 2006 3 70 doi l743-422X-3-70 This article is available from http content 3 1 70 2006 Szécsi et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Summary There is an urgent need to develop novel approaches to vaccination against the emerging highly pathogenic avian .